Hughes Financial Services »

Castle Biosciences shares owned by Hughes Financial Services

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Hughes Financial Services from 13F filings

Historical chart of Hughes Financial Services investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Hughes Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Hughes Financial Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $15k 435 34.74
2025-06-30 $8.6k 435 19.76
2025-03-31 $8.6k 435 19.78

More positions owned by Hughes Financial Services

State Street Spdr Portfolio S&p 1500 Composite Stock Market Etf Etf (SPTM)
Jpmorgan Core Plus Bond Etf Etf (JCPB)
Jpmorgan International Research Enhanced Equity Etf Etf (JIRE)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Jpmorgan U.s. Tech Leaders Etf Etf (JTEK)
Ishares Core Dividend Growth Etf Etf (DGRO)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Jpmorgan International Bond Opportunities Etf Of Benef Interest Etf (JPIB)
State Street Spdr Portfolio Tips Etf Etf (SPIP)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Dimensional U.s. Equity Market Etf Etf (DFUS)
Ishares 10-20 Year Treasury Bond Etf Etf (TLH)
Jpmorgan Hedged Equity Laddered Overlay Etf Etf (HELO)
State Street Spdr Msci Usa Strategicfactors Etf Etf (QUS)
Vanguard Ftse All-world Ex-us Index Fund Etf (VEU)

View all positions for Hughes Financial Services

Top funds holding Castle Biosciences

BlackRock
Vanguard Group
Principal Financial Group
Portolan Capital Management
Dimensional Fund Advisors
Nuveen
Braidwell
State Street Corporation
AIGH Capital Management
Geode Capital Management
Daniel D. Thurber
Allianz Asset Management
Palisade Capital Management
Millennium Management
Renaissance Technologies

View all funds holding Castle Biosciences